Eli Lilly to Build $6.5 Billion Ingredient-Manufacturing Facility in Texas

Core Insights - The company plans to establish a site for the production of its first oral weight-loss drug, which is anticipated to be operational within five years [1] Company Developments - The new manufacturing site will focus on the production of an oral weight-loss medication, indicating a strategic move into the weight management market [1]